Company · CIK 0001231457 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
GENELUX Corp · GNLX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 SForm 4 → | Sep 2, 7:05 pm EDT | Joseph CappelloChief Technical Officer | 10,257 | $2.74 | $28,112 | 318,480 | −3.12% | |
| Aug 31, 2026 SForm 4 → | Sep 2, 7:05 pm EDT | Thomas ZindrickPresident and CEO | 34,463 | $2.67 | $91,899 | 1,226,427 | −2.73% | |
| Aug 31, 2026 SForm 4 → | Sep 2, 7:05 pm EDT | Yong YuChief Scientific Officer | 9,683 | $2.75 | $26,658 | 258,688 | −3.61% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.